In PC, we described that the percentage of patients positives to all the IAPs family members studied is similar (c-IAP1/2, NAIP or XIAP), major (ILP-2, Survivin) or minor (c-IAP-2) than in BPH. This evidence concerns the gene BIRC3 and benign prostatic hyperplasia.